SFB 490: Invasion und Persistenz bei Infektionen
Forschungsverbund / Johannes Gutenberg-Universität Mainz
Erlach, KC; Bohm, V; Knabe, M et al.
Activation of hepatic natural killer cells and control of liver-adapted lymphoma in the murine model of cytomegalovirus infection.Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 167-78
Holtappels, R; Janda, J; Thomas, D et al.
Adoptive CD8 T cell control of pathogens cannot be improved by combining protective epitope specificities.J Infect Dis. Bd. 197. H. 4. 2008 S. 622-9
Holtappels, R; Bohm, V; Podlech, J et al.
CD8 T-cell-based immunotherapy of cytomegalovirus infection: "proof of concept" provided by the murine model.Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 125-34
Fassbender, M; Herter, S; Holtappels, R et al.
Correlation of dendritic cell maturation and the formation of aggregates of poly-ubiquitinated proteins in the cytosol.Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 185-9
Cicin-Sain, L; Ruzsics, Z; Podlech, J et al.
Dominant-negative FADD rescues the in vivo fitness of a cytomegalovirus lacking an antiapoptotic viral gene.J Virol. Bd. 82. H. 5. 2008 S. 2056-64
Bohm, V; Podlech, J; Thomas, D et al.
Epitope-specific in vivo protection against cytomegalovirus disease by CD8 T cells in the murine model of preemptive immunotherapy.Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 135-44
Seckert, CK; Renzaho, A; Reddehase, MJ et al.
Hematopoietic stem cell transplantation with latently infected donors does not transmit virus to immunocompromised recipients in the murine model of cytomegalovirus infection.Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 251-9
Reddehase, MJ; Simon, CO; Seckert, CK et al.
Murine model of cytomegalovirus latency and reactivation.Curr Top Microbiol Immunol. Bd. 325. 2008 S. 315-31
Wirtz, N; Schader, SI; Holtappels, R et al.
Polyclonal cytomegalovirus-specific antibodies not only prevent virus dissemination from the portal of entry but also inhibit focal virus spread within target tissues.Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 151-8
Besold, K; Plachter, B
Recombinant viruses as tools to study human cytomegalovirus immune modulationMed Microbiol Immunol. Bd. 197. H. 2. 2008 S. 215-222
Mersseman, V; Bohm, V; Holtappels, R et al.
Refinement of strategies for the development of a human cytomegalovirus dense body vaccine.Med Microbiol Immunol. Bd. 197. H. 2. 2008 S. 97-107
Holtappels, R; Simon, CO; Munks, MW et al.
Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination.J Virol. Bd. 82. H. 12. 2008 S. 5781-96
Sacher, T; Podlech, J; Mohr, CA et al.
The major virus-producing cell type during murine cytomegalovirus infection, the hepatocyte, is not the source of virus dissemination in the host.Cell Host Microbe. Bd. 3. H. 4. 2008 S. 263-72
Selinka, HC; Florin, L; Patel, HD et al.
Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus.J Virol. Bd. 81. H. 20. 2007 S. 10970-80
Simon, CO; Kühnapfel, B; Reddehase, MJ et al.
Murine Cytomegalovirus Major Immediate Early Enhancer Region Operating as a Genetic Switch in Bidirectional Gene Pair TranscriptionJ Virol. Bd. 81. H. 14. 2007 S. 7805-7810
Besold, K; Frankenberg, N; Pepperl-Klindworth, S et al.
Processing and MHC class I presentation of human cytomegalovirus pp65-derived peptides persist despite gpUS2-11-mediated immune evasionJ Gen Virol. Bd. 88. 2007 S. 1429-1439
Simon, CO; Holtappels, R; Tervo, HM et al.
CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation.J Virol. Bd. 80. H. 21. 2006 S. 10436-56
Holtappels, R; Munks, MW; Podlech, J et al.
CD8 T-cell-based immunotherapy of cytomegalovirus disease in the mouse model of the immunocompromised bone marrow transplantation recipientM. J. Reddehase (ed.), Cytomegaloviruses: molecular biology and immunology. 1. Aufl. Wymondham, Norfolk, United Kingdom: Caister Academic Press 2006
Holtappels, R; Gillert-Marien, D; Thomas, D et al.
Cytomegalovirus encodes a positive regulator of antigen presentation.J Virol. Bd. 80. H. 15. 2006 S. 7613-24
Pepperl-Klindworth, S; Besold, K; Frankenberg, N et al.
Cytomegalovirus Interleukin-10 Expression in Infected Cells Does Not Impair MHC Class I Restricted Peptide Presentation on Bystanding Antigen-Presenting CellsViral Immunol. Bd. 19. H. 1. 2006 S. 92-101
Simon, CO; Seckert, CK; Grzimek, NKA et al.
Cytomegalovirus Latency and Reactivation: the Silencing/Desilencing and Immune Sensing HypothesisCytomegaloviruses: molecular biology and immunology. 1. Aufl. Norfolk, U.K.: Caister Academic Press 2006
Reddehase, MJ
Cytomegaloviruses: molecular biology and immunologyEditor. 1. Aufl. Norfolk, United Kingdom: Caister Academic Press Wymondham 2006
Rost, M; Mann, S; Lambert, C et al.
Gamma-adaptin, a novel ubiquitin-interacting adaptor, and Nedd4 ubiquitin ligase control hepatitis B virus maturation.J Biol Chem. Bd. 281. H. 39. 2006 S. 29297-308
Erlach, KC; Böhm, V; Seckert, CK et al.
Lymphoma cell apoptosis in the liver induced by distant murine cytomegalovirus infection.J Virol. Bd. 80. H. 10. 2006 S. 4801-19